HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART) [Phase 1]
Phase 1 clinical trial evaluating effects of vorinostat and HXTC on persistent HIV-1 infection in patients on ART has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis [Phase 4]
Phase 4 clinical trial evaluating switching to Emtricitabine/Tenofovir Alafenamide for HIV pre-exposure prophylaxis in transgender individua…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Empiric Treatment for Acute HIV in the ED [Phase 4]
Phase 4 clinical trial update evaluating empiric treatment for acute HIV infection in the emergency department.
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection [Phase 3]
Phase 3 trial update for UB-421 combined with an optimized background regimen in patients with multi-drug resistant HIV-1 infection; study s…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients [Phase 2]
Phase 2 clinical trial update investigating UB-421 with an optimized background regimen in patients with multi-drug resistant HIV-1 infectio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Suppression of HIV 1 RNA in People Living With HIV [NA]
Clinical trial update reporting suppression of HIV-1 RNA in people living with HIV; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk [Phase 2]
Phase 2 trial evaluating IL-1β inhibition to reduce inflammation and cardiovascular risk in people with HIV and cardiovascular disease; resu…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa [Phase 2]
Phase 2 trial examining a heterologous prime/boost HIV vaccine regimen (Ad26.Mos4.HIV and aluminum phosphate-adjuvanted gp140) in women in S…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Linking Infectious and Narcology Care-Part II [Phase 4]
Phase 4 clinical trial assessing integration of infectious disease and narcology care for people with HIV infection and drug use; completed …
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: [Phase 2]
A Phase 2 clinical trial evaluating whether BCG vaccination affects latent HIV-1 reservoir size in treated HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients [Phase 2]
Phase 2 clinical trial investigating the effects of cannabidiol (CBD) on autophagy and inflammation gene activation in virologically control…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults [Phase 1, Phase 2]
Phase 1/2 safety, pharmacokinetics, and pharmacodynamics study of ABX464 in HIV-1 seronegative and seropositive adults completed with posted…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients [Phase 2]
Phase 2 trial update on the safety and efficacy of T8 for chronic abnormal immune activation in HIV/AIDS patients.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women [Phase 3]
Phase 3 trial update comparing long-acting injectable cabotegravir with daily oral TDF/FTC for HIV pre-exposure prophylaxis in HIV-uninfecte…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: The Risk of HIV Acquisition Among Traditional Healers in South Africa [NA]
This completed clinical trial evaluated the risk of HIV infection among traditional healers in South Africa, with results posted in March 20…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) [Phase 2]
This is a Phase 2 update on the safety and pharmacokinetics of once-monthly oral islatravir (MK-8591). The MK-8591-016 trial studied partici…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Change the Cycle: An RCT to Prevent Injection Initiation [NA]
An RCT evaluating strategies to prevent initiation of injection use in individuals, completed with posted results in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults [Phase 3]
Phase 3 trial comparing Bictegravir/Emtricitabine/Tenofovir Alafenamide to a Dolutegravir-based regimen in treatment-naive adults co-infecte…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa [Phase 3]
A Phase 3 clinical trial update for early empiric anti-tuberculosis therapy in sepsis patients in Sub-Saharan Africa is reported as status u…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke [Phase 3]
A Phase 3 trial investigating strategies to optimize smoking cessation in people living with HIV/AIDS has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated Brentuximab Vedotin in combination chemotherapy for AIDS-related Hodgkin lymphoma in HIV-infected pati…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028) [Phase 2]
Phase 2 pediatric trial update for Doravirine/Islatravir in children under 18 years weighing at least 35 kg with HIV-1; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM [NA]
A pragmatic clinical trial evaluating MyPEEPS Mobile to improve HIV prevention behaviors in diverse adolescent men who have sex with men has…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Gardasil Immunogenicity With Needle-Free Injection [Phase 2]
Phase 2 trial update evaluating immunogenicity of Gardasil delivered by a needle-free injection in HIV-related conditions has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs [Phase 2]
Phase 2 proof-of-concept trial evaluating UB-421 plus chidamide for safety and efficacy in changing HIV reservoirs has completed.